Ann: Chairman's Address to Shareholders , page-9

It may be, probably for the first time in the 5 years I've held this stock, that we have our timing impeccable. Biotech stocks in Australia have seen excellent growth and attention since about June. Some, such as AHZ, have become market darlings. What a great time to be completing phIII trials, be funded, with income, and have some big pharma partners.

I've never felt so positive about our company.